Intech Investment Management LLC Exelixis, Inc. Transaction History

Intech Investment Management LLC

  • $8.75 Billion
  • Q3 2024

A detailed history of Intech Investment Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 232,041 shares of EXEL stock, worth $7.69 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
232,041
Previous 156,552 48.22%
Holding current value
$7.69 Million
Previous $3.52 Million 71.2%
% of portfolio
0.07%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$21.96 - $27.6 $1.66 Million - $2.08 Million
75,489 Added 48.22%
232,041 $6.02 Million
Q2 2024

Aug 12, 2024
BUY
$20.34 - $23.73 $1.15 Million - $1.34 Million
56,513 Added 56.49%
156,552 $3.52 Million
Q1 2024

May 10, 2024
BUY
$20.17 - $23.93 $1.23 Million - $1.46 Million
60,925 Added 155.76%
100,039 $2.37 Million
Q4 2023

Oct 18, 2024
BUY
$19.25 - $24.13 $21,425 - $26,856
1,113 Added 2.93%
39,114 $938,000
Q4 2023

Feb 09, 2024
BUY
$19.25 - $24.13 $21,425 - $26,856
1,113 Added 2.93%
39,114 $938,000
Q3 2023

Oct 18, 2024
SELL
$19.04 - $22.74 $285,771 - $341,304
-15,009 Reduced 28.31%
38,001 $830,000
Q3 2023

Nov 13, 2023
SELL
$19.04 - $22.74 $285,771 - $341,304
-15,009 Reduced 28.31%
38,001 $830,000
Q2 2023

Oct 18, 2024
SELL
$18.17 - $20.48 $657,426 - $741,007
-36,182 Reduced 40.57%
53,010 $1.01 Million
Q2 2023

Aug 09, 2023
SELL
$18.17 - $20.48 $657,426 - $741,007
-36,182 Reduced 40.57%
53,010 $1.01 Million
Q1 2023

Oct 18, 2024
SELL
$16.3 - $19.41 $1.1 Million - $1.31 Million
-67,360 Reduced 43.03%
89,192 $1.73 Million
Q1 2023

May 10, 2023
SELL
$16.3 - $19.41 $490,939 - $584,609
-30,119 Reduced 25.24%
89,192 $1.73 Million
Q4 2022

Oct 18, 2024
SELL
$14.96 - $17.39 $207,644 - $241,373
-13,880 Reduced 10.42%
119,311 $1.91 Million
Q4 2022

Feb 09, 2023
SELL
$14.96 - $17.39 $207,644 - $241,373
-13,880 Reduced 10.42%
119,311 $1.91 Million
Q3 2022

Oct 18, 2024
SELL
$15.68 - $22.27 $366,300 - $520,249
-23,361 Reduced 14.92%
133,191 $2.09 Million
Q3 2022

Nov 10, 2022
BUY
$15.68 - $22.27 $2.09 Million - $2.97 Million
133,191 New
133,191 $2.09 Million

Others Institutions Holding EXEL

# of Institutions
520
Shares Held
244M
Call Options Held
2.84M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $10.7B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email